925 West Georgia St, Suite 1600, Cathedral Pl, Vancouver, BC
Year called to bar: 2001 (British Columbia)
Stuart is the head of the Corporate Finance and Securities Group at Lawson Lundell. His practice focuses on corporate and commercial law, with an emphasis on corporate finance and securities and mergers & acquisitions. Stuart has acted for domestic and international companies in a wide variety of transactions including equity and debt financings, business combinations, acquisitions, and stock exchange listings. He also advises clients on corporate and securities regulatory compliance issues and corporate governance matters. Stuart has extensive experience acting for clients involved in the mineral exploration, development, and mining industry, including advising clients on and completing commercial transactions such as joint ventures, option/earn-ins, royalties, strategic investments, and asset acquisitions. He also regularly provides advice on the unique continuous disclosure requirements of companies in the mining industry. Stuart is recognized by TheBest Lawyersin Canada for M&A, mining law, and securities law and by Who's Who Legal: Canada and Chambers Canada for his mining expertise. He is called to the British Columbia Bar (2001).
Tekmira Pharmaceuticals Corporation (“Tekmira”) completed a merger of equals with OnCore Biopharma, Inc. (“OnCore”) whereby OnCore merged with a wholly-owned subsidiary of Tekmira. As a result of the merger, stockholders of OnCore hold approximately fifty per cent (50%) of the total number of outstanding shares of capital stock of Tekmira. The implied market value of the combined company, based on the closing price of Tekmira common shares on the NASDAQ Global Market on January 9, 2015, was approximately USD$750 million and at time of closing USD$964 million.